Relmada Therapeutics Inc.

RLMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.21

+$0.05 (+1.20%)

Sep 22, 2026, 10:22 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $436.34M

Enterprise Value $218.61M

Beta 0.45

Average Volume 1.49M

Shares Outstanding (Diluted) 112.38M

Shares Change YoY 238.57%

Institutional Ownership 97.83%

Exchange NASDAQ

ISIN US75955J4022

Price Performance

Price Change 1M -9.8%

Price Change 3M -38.5%

Price Change 6M -37.5%

Price Change YTD -4.8%

Price Change 1Y 152.1%

Price Change 3Y 496.4%

Price Change 5Y -28.5%

1M CAGR (ann.) -15.8%

1Y CAGR (ann.) 152.1%

5Y CAGR (ann.) -4.8%

All-Time CAGR -8.3%

Valuation

PE Ratio -4.52

Forward PE N/A

PEG Ratio -0.04

Forward PEG -0.16

PS Ratio N/A

Forward PS 13.40

PB Ratio 2.11

P/FCF Ratio -7.15

P/Adj. FCF Ratio -5.95

P/OCF Ratio -10.15

EV/Sales N/A

EV/EBIT -3.53

EV/EBITDA -3.53

EV/FCF -3.58

Earnings Yield -22.1%

FCF Yield -14.0%

Adj. FCF Yield -16.8%

Financial Health

Net Cash $217.73M

Total Debt $0

Cash & Short-Term Investments $217.73M

Total Assets $219.06M

Current Ratio 29.52

Quick Ratio 29.52

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 16.50

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -20.2%

Returns

Return on Assets -28.3%

Return on Equity -47.5%

Return on Invested Capital -30.8%

Return on Capital Employed -30.8%

Return on Tangible Assets -28.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 48.8%

EPS CAGR 5Y 41.0%

EPS CAGR 10Y 1.5%

FCF CAGR 3Y -12.1%

FCF CAGR 5Y 17.0%

FCF CAGR 10Y -17.4%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 3.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.14

EPS Growth Est (next Q) -53.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $12

Price Target Upside 188.5%

Cash Flow

Operating Cash Flow $-61.06M

Free Cash Flow $-61.06M

Adj. Free Cash Flow $-73.37M

FCF Per Share -$0.41

OCF Per Share -$0.41

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-65.13M

EBITDA $-61.93M

Net Income $-61.93M

EPS (Diluted) -$0.92

Revenue / Employee N/A

Profit / Employee $-3.64M

Employees 17